<PAGE>
================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
AMENDMENT NO. 2
TO
SCHEDULE 14D-1
TENDER OFFER STATEMENT PURSUANT TO
SECTION 14(D)(1) OF THE SECURITIES EXCHANGE ACT OF 1934
NELLCOR PURITAN BENNETT INCORPORATED
(NAME OF SUBJECT COMPANY)
NPB ACQUISITION CORP.
(BIDDER)
COMMON STOCK, PAR VALUE $.001 PER SHARE
(Title of Class of Securities)
640275 10 3
(CUSIP NUMBER OF CLASS OF SECURITIES)
ROGER A. KELLER, ESQ.
VICE PRESIDENT, SECRETARY AND GENERAL COUNSEL
MALLINCKRODT INC.
7733 FORSYTH BOULEVARD
ST. LOUIS, MISSOURI 63105-1820
(314) 854-5200
COPY TO:
JAMES C. MORPHY, ESQ.
SULLIVAN & CROMWELL
125 BROAD STREET
NEW YORK, NEW YORK 10004
(212) 558-4000
(NAME, ADDRESS, AND TELEPHONE NUMBERS OF PERSON AUTHORIZED
TO RECEIVE NOTICES AND COMMUNICATIONS ON BEHALF OF BIDDER)
================================================================================
<PAGE>
CUSIP NO. 640275103 14D-1
---------
- --------------------------------------------------------------------------------
1. NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
MALLINCKRODT INC.
- --------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [_]
(b) [_]
- --------------------------------------------------------------------------------
3. SEC USE ONLY
- --------------------------------------------------------------------------------
4. SOURCE OF FUNDS
BK
- --------------------------------------------------------------------------------
5. CHECK THE BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEM 2(e) or 2(f) [_]
- --------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
NEW YORK
- --------------------------------------------------------------------------------
7. AGGREGATE AMOUNT BENEFICALLY OWNED BY EACH REPORTING PERSON
APPROXIMATELY 61,705,005 SHARES OF COMMON STOCK, PAR VALUE $.001 PER
SHARE
- --------------------------------------------------------------------------------
8. CHECK THE BOX IF THE AGGREGATE AMOUNT IN ROW (7) EXCLUDES
CERTAIN SHARES [_]
- --------------------------------------------------------------------------------
9. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (7)
APPROXIMATELY 96%
- --------------------------------------------------------------------------------
10. TYPE OF REPORTING PERSON
CO
- --------------------------------------------------------------------------------
CUSIP NO. 640275103 14D-1
---------
<PAGE>
- --------------------------------------------------------------------------------
1. NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
NPB ACQUISITION CORP.
- --------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [_]
(b) [_]
- --------------------------------------------------------------------------------
3. SEC USE ONLY
- --------------------------------------------------------------------------------
4. SOURCE OF FUNDS
AF
- --------------------------------------------------------------------------------
5. CHECK THE BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEM 2(e) or 2(f) [_]
- --------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
DELAWARE
- --------------------------------------------------------------------------------
7. AGGREGATE AMOUNT BENEFICALLY OWNED BY EACH REPORTING PERSON
APPROXIMATELY 61,705,005 SHARES OF COMMON STOCK, PAR VALUE $.001 PER
SHARE
- --------------------------------------------------------------------------------
8. CHECK THE BOX IF THE AGGREGATE AMOUNT IN ROW (7) EXCLUDES
CERTAIN SHARES [_]
- --------------------------------------------------------------------------------
9. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (7)
APPROXIMATELY 96%
- --------------------------------------------------------------------------------
10. TYPE OF REPORTING PERSON
CO
- --------------------------------------------------------------------------------
<PAGE>
This Amendment No. 2 amends and supplements the information set forth in
the Tender Offer Statement on Schedule 14D-1 filed by NPB Acquisition Corp. (the
"Merger Sub") and Mallinckrodt Inc. ("Mallinckrodt") on July 29, 1997 as amended
by Amendment No. 1 to such Schedule, dated August 19, 1997, with respect to
shares of Common Stock, par value $.001 per share, of Nellcor Puritan Bennett
Incorporated (the "Company"). Unless otherwise indicated, the capitalized terms
used herein shall have the meanings specified in the Schedule 14D-1 including
the Offer to Purchase filed as Exhibit (1) thereto.
ITEM 6. INTEREST IN SECURITIES OF THE SUBJECT COMPANY.
On August 26, 1997, the Purchaser accepted for payment all of the
approximately 61,705,005 Shares which were validly tendered pursuant to the
Offer and not withdrawn, including approximately 3,272,261 Shares tendered
pursuant to Notices of Guaranteed Delivery.
ITEM 11. MATERIAL TO BE FILED AS EXHIBITS.
(16) Press Release dated August 26, 1997.
<PAGE>
SIGNATURE
After due inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
Date: August 26, 1997
Mallinckrodt Inc.
By: /s/ C. Ray Holman
-------------------------
Name: C. Ray Holman
Title: Chairman and Chief
Executive Officer
NPB Acquisition Corp.
By: /s/ C. Ray Holman
-------------------------
Name: C. Ray Holman
Title: Chairman and Chief
Executive Officer
<PAGE>
Exhibit 16
[LETTERHEAD OF MALLINCKRODT]
NEWS RELEASE
Mallinckrodt Inc.
7733 Forsyth Boulevard
St. Louis, Missouri 63105
FOR IMMEDIATE RELEASE Telephone (314) 854-5200
- --------------------- Facsimile (314) 854-5381
For more information:
Media Contacts: Peter Faur, (314) 854-5234
Barbara Abbett, (314) 854-5230
E-mail: [email protected]
Investors Contacts: Doug McKinney, (314) 854-5264
Scott Johnsen, (314) 854-5295
E-mail: [email protected]
MALLINCKRODT ANNOUNCES COMPLETION OF ITS TENDER OFFER
FOR NELLCOR PURITAN BENNETT
ST. LOUIS, Missouri, August 26, 1997 - Mallinckrodt, Inc. (NYSE:MKG) today
announced the successful completion of its all-cash tender offer for all of the
outstanding shares of common stock of Nell Nellcor Puritan Bennett Incorporated
(NASDAQ/NMS:NELL). The tender offer expired at midnight New York City time on
August 25, 1997. Today, Mallinckrodt's wholly owned subsidiary, NPB Acquisition
Corporation, accepted for payment all of the approximately 59,066740 shares that
were validly tendered and not withdrawn, including approximately 1,094,154
shares tendered pursuant to notices of guaranteed delivery. The shares tendered
represent more than 90 percent of the outstanding shares of Nellcor Puritan
Bennett.
Mallinckrodt said it expects it will soon complete the acquisition of Nellcor
Puritan Bennett by a merger of NPB Acquisition Corporation into Nellcor Puritan
Bennett, in which the remaining shares of Nellcor Puritan Bennett common stock
will be converted into the right to receive $28.50 per share in cash.
"We are delighted that our tender offer has met with success." said C. Ray
Holman, chairman and chief executive officer of Mallinckrodt Inc. "The
combination of Nellcor Puritan Bennett and Mallinckrodt creates the leading
business serving the anesthesia and respiratory care markets. Along with our
medical imaging and specialty pharmaceutical divisions, Mallinckrodt becomes a
more powerful healthcare force serving hospital, alternate care and
pharmaceutical markets. We look forward to working with Nellcor in bringing our
two companies together, and we remain confident in achieving the objective
expressed at the time of our announcement last month."
Nellcor Puritan Bennett is the world leader in providing products that
monitor, diagnose and treat the respiratory-impaired patient in every setting
from the hospital to the home. Products include devices that aid in sleep
diagnosis, oxygen monitoring, apnea monitors, critical care ventilators, oxygen
concentrators and anesthetic gases. The company's web site address is
(www.nellcorpb.com).
Mallinckrodt Inc. serves healthcare and specialty chemicals markets
worldwide. The company is a major producer of diagnostic imaging agents, medical
devices, analgesic pharmaceuticals, catalysts, and laboratory and
microelectronic chemicals. The St. Louis, Missouri-based company, with fiscal
1997 sales of $1.9 billion, sells more than 1,000 products in more than 100
countries. The Mallinckrodt web site address is (www.mallinckrodt.com).
###
This news release contains forward-looking statements. These statements are
based on current expectation; actual results may differ materially. Among the
factors that could cause actual results to differ materially are the following:
the effect of business and economic conditions: the impact of competitive
products and continued pressure on prices realized by Mallinckrodt for its
products; market acceptance issues, including the failure of new products to
generate anticipated sales levels; difficulties or delays in receiving required
governmental or regulatory approvals; the cost and effect of legal and
administrative proceedings; and the other risk factors reported from time to
time in Mallinckrodt's filings with the Securities and Exchange Commission.
